Zoperil

Quick links to important sections

Zoperil

Method of action: Hypnotic

Treatment option: Insomnia

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zoperil

Quick Facts

Property Description
Active ingredient Zopiclone
Form Oral formulation (Tablet)
Pharmacological class Sedative-Hypnotic, Non-benzodiazepine (Cyclopyrrolone)
Common use Temporary management of sleep disorder difficulties (Insomnia)
Origin Synthetic

What Type of Medicine is Zoperil (Zopiclone)?

Zoperil is a brand-name, prescription sedative-hypnotic medication used for the temporary management of difficulties related to a sleep disorder. The active pharmaceutical ingredient is Zopiclone, a synthetic compound classified as a central nervous system depressant. This classification is clinically recognized for its effectiveness in promoting sleep onset.

The Zopiclone molecule belongs to the cyclopyrrolone chemical class and is commonly grouped as a Z-drug. Its mechanism involves acting as a GABAA receptor positive allosteric modulator, which enhances the inhibitory effects of GABA (gamma-aminobutyric acid), the brain's main calming neurotransmitter. The Z-drug structure chemically distinguishes it from the older benzodiazepines, and it maintains a functional similarity to benzodiazepine-related substances.


Composition, Form, and General Purpose

The standard preparation of Zoperil is an oral formulation, typically a film-coated tablet, containing Zopiclone as the sole therapeutic agent, making it a single-active-ingredient product. This tablet form is designed for oral route of administration. The general purpose of this medication is to provide temporary support by promoting sedation to help patients initiate sleep more quickly.

The pharmacological effect is achieved through its modulating action on the GABAA receptor complex, which increases the natural inhibitory signal in the brain. This selective mechanism allows the medication to assist with both sleep initiation and the overall sleep maintenance in a scenario where a person experiences severe difficulty falling or staying asleep.

What side effects are possible with Zoperil?

Possible Side Effects and Safety Information

The safety profile of Zoperil is defined by adverse reactions documented in official government regulatory documents. These reactions are categorized by frequency and system-organ class, with specific warnings reserved for the most serious events.

Serious and Clinically Significant Adverse Reactions

The most serious safety concerns include reports of complex sleep-related behaviors, such as driving, preparing and eating food, or making phone calls while not fully awake. Severe hypersensitivity reactions, including angioedema (swelling of the face, tongue, or throat), have also been documented. These serious events require prominent warnings in the regulatory labeling.

Common Adverse Reactions

Adverse effects commonly reported (affecting between 1 in 10 and 1 in 100 people) primarily involve the central nervous system (CNS) and gastrointestinal system. These include somnolence (drowsiness), dizziness, headache, nausea, and diarrhea. The risk of next-day impairment, which can affect motor coordination and alertness, is a key consideration, especially with higher doses.

Population-Specific Risks and Limitations

Safety-related restrictions emphasize that the medicine is contraindicated in patients with known severe liver impairment due to increased drug exposure. Elderly patients are at an increased risk of CNS adverse effects and are officially advised to use a lower starting dose. There is also a documented risk of abnormal thinking, worsening of depression, and potential withdrawal symptoms if the medicine is discontinued suddenly, necessitating gradual cessation.

Overdose and Emergency Response

The official regulatory documentation for Zoperil (Zopiclone) defines overdose as a severe manifestation of Central Nervous System (CNS) depression. Documented clinical presentations range from milder signs, such as prolonged sleep, drowsiness, lethargy, and confusion, to severe symptoms involving loss of motor control. These may include ataxia (loss of coordination), hypotonia (muscle weakness), and hypotension (low blood pressure), with the potential to progress to profound respiratory depression and coma.

Regulators explicitly warn that the risk of life-threatening outcomes is substantially increased when Zoperil is ingested concurrently with other CNS depressants, particularly alcohol and opioids. For any suspected overdose, the official guidance mandates that patients or caregivers seek immediate medical attention or go to the emergency department straight away. Hospitalization and close monitoring are required for management.

Official intervention procedures focus on providing symptomatic and supportive treatment to maintain vital functions. Decontamination measures, such as gastric lavage and/or administration of activated charcoal, are described as potential supportive actions. Elderly patients are identified as a population with heightened risk, facing increased potential for complications like falls and aggravated psychomotor impairment during an overdose event.

Therapeutic Uses of Zoperil

What Zoperil Treats: Main Uses and Benefits

Zoperil is commonly used for the temporary management of a sleep disorder known as insomnia, particularly in conditions characterized by periods of heightened symptoms or significant distress. The medication is relevant for addressing symptom clusters related to difficulty falling asleep (sleep initiation) and frequent nocturnal awakenings (sleep maintenance). Clinical contexts often involve acute phases or transient sleeplessness, such as those associated with temporary high tension or situational stress, commonly used when short-term symptomatic assistance is needed and symptoms are disruptive.

The medication is relevant for offering supportive relief, which helps ease the overall symptom burden. This may assist patients in obtaining a more sustained period of sleep, contributing to supporting daytime functioning and general comfort.

“This medication is considered relevant for easing symptoms that interfere with daily stability and functional well-being.”


Quick Fact: Relief for Sleep Initiation

Property Description
Primary Use Temporary management of severe insomnia
Symptom Focus Difficulty falling asleep and nocturnal awakenings
Clinical Context Acute or transient symptomatic episodes
Core Benefit Supports a more sustained period of sleep

Eligibility and Restrictions for Use

Eligibility to Use Zoperil (Zopiclone) — Official Regulatory Information

Zoperil is strictly for use in adults (18 years and older) and is not recommended for use in children or adolescents, as safety and efficacy have not been established in the pediatric population.

Contraindications (Must Not Use)

Zoperil is contraindicated in patients with the following severe conditions or histories:

Contraindicated Group Reason for Prohibition
Hypersensitivity Known allergy to zopiclone or any excipients.
Myasthenia Gravis Severe muscle weakness.
Severe Hepatic Insufficiency Severe liver problems.
Respiratory Failure Lungs do not work properly.
Severe Sleep Apnoea Syndrome Stops breathing for short periods at night.
Complex Sleep Behaviors Previously experienced sleep-driving, sleepwalking, or other abnormal behaviors after taking zopiclone.

Restrictions and Special Considerations

Use is restricted or requires special consideration in several patient groups, often necessitating a lower dose:

  • Elderly Patients: A reduced dose (e.g., 3.75 mg) is recommended due to increased sensitivity and risk of side effects like confusion and falls.
  • Renal Insufficiency: A lower dose is recommended.
  • Chronic Respiratory Insufficiency: A reduced dose is recommended due to the risk of respiratory depression.
  • History of Abuse: Patients with a history of drug or alcohol abuse or dependence must use the medicine with extreme caution.
  • Depression: The least possible quantity should be prescribed due to the risk of intentional overdose.

What should I know about interactions with other medicines?

Zoperil Interactions with other medicines and products

Zoperil (eszopiclone) can interact with other medicines and substances, primarily due to its effects on the central nervous system (CNS) and its metabolism by the body's enzyme systems.

Additive CNS Depression

Concomitant use of Zoperil with other CNS depressants can lead to additive effects, increasing the risk of severe drowsiness, respiratory depression, complex sleep behaviors (e.g., sleep-driving with amnesia), and potential next-day impairment. Products with this interaction include:

  • Alcohol (Ethanol): Consumption of alcohol is not recommended as it significantly increases the risk of side effects and impairment.
  • Opioid medicines and other sedative/hypnotics.
  • Medicines for depression or anxiety (e.g., tricyclic antidepressants, benzodiazepines).

Metabolic Interactions

Zoperil is broken down in the liver primarily by the CYP3A4 enzyme. This can cause two types of interactions:

Interacting Product Category Effect on Zoperil Level Clinical Impact
Potent CYP3A4 Inhibitors (e.g., ketoconazole, clarithromycin) Increased Concentration Elevated risk of Zoperil side effects; requires dose reduction (e.g., do not exceed 1 mg starting dose).
Potent CYP3A4 Inducers (e.g., rifampicin, St John’s Wort) Decreased Concentration Reduced effectiveness of Zoperil.

Administration with or immediately after a high-fat meal may also reduce Zoperil's rate of absorption, which could decrease its effect on sleep onset.

Mechanism of Action

Central Nervous System Receptor Modulation

Zoperil acts as a positive allosteric modulator at the GABA A receptor complex, a ligand-gated ion channel located primarily on neuronal membranes within the central nervous system. The drug engages specific binding sites on the receptor structure to influence its conformational dynamics.


Enhanced Inhibitory Signaling Cascade

The binding of Zoperil enhances the inhibitory effects of the endogenous gamma-aminobutyric acid ( GABA) neurotransmitter, which increases the frequency or duration of chloride ion channel opening. This modification initiates a signaling sequence that leads to increased neuronal hyperpolarization across the synapse.


Downstream Physiological Adjustment

The mechanistic consequence of heightened GABAergic activity is the generalized modulation of neural activity within targeted central pathways. This process results in a broad reduction in central nervous system excitability, which defines the compound's core pharmacological effect profile.

Dosage and Administration Information

Zoperil (Zopiclone) is used strictly according to a single-dose, short-term administration protocol. The medication is an oral formulation, typically a film-coated tablet, which must be swallowed whole with water without crushing or chewing. Its use is limited to a single intake once daily, administered immediately before retiring for the night. This specific timing requires that a full seven to eight hours of dedicated sleep time must be possible after the dose is taken.

The standard administration schedule for adults typically specifies a single dose of 7.5 mg. This quantity also serves as the maximum approved dose that may be taken within a 24-hour period. Dosing adjustments are required for specific populations to manage systemic exposure. Older adults, as well as patients presenting with reduced liver function, kidney impairment, or chronic respiratory insufficiency, are instructed to initiate treatment at a lower dose of 3.75 mg.

The overall course of treatment is typically short-term, defining the usage pattern as a brief intervention. The total duration of use should not exceed four continuous weeks. This four-week limit includes any time spent gradually reducing the dose (tapering off) before final discontinuation. If a dose is missed, it must not be taken later if the patient cannot guarantee the full 7-8 hours of dedicated sleep, and the medication should never be re-administered within the same night.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Zoperil (Zopiclone)

Evidence from Short-Term Clinical Trials

Research exploring Zoperil was evaluated in numerous short-term clinical trials, primarily involving Randomized Controlled Trials (RCTs) and meta-analyses. These studies compared the experience of adults with temporary sleep difficulties to those receiving an inactive placebo or another compound. The research examined outcomes describing episodic or acute changes in sleep patterns.

Studies monitored how long it took participants to fall asleep (Sleep Onset Latency) and the total time they spent sleeping (Total Sleep Time). Additionally, researchers described patient-reported outcomes relating to perceived discomfort and overall sleep quality. The evidence derived from these settings focused on short-term symptom changes and periods of heightened symptom activity, typically over follow-up durations of a few nights up to four weeks.

Findings describe patterns observed in the studies where participants receiving the medication reported changes in the time taken to fall asleep compared to measurements reported by those receiving placebo. Research also monitored measurements related to the reported frequency of nocturnal awakenings. Research provides context but not individual predictions, and the duration of the research was limited to short-term durations.

The Research Landscape: Long-Term Studies and Follow-up

The body of research focusing on Zoperil's use beyond the initial few weeks is significantly different. There is limited information for long-term outcomes that come from high-quality, continuous randomized controlled trials. Instead, long-term knowledge is often derived from observational settings evaluating daily-life functioning in individuals classified as chronic users.

Observational evidence and chronic user studies monitored reported sleep quality over time. Research examined whether these reports differed from those given by individuals with untreated chronic sleep issues.

Because follow-up durations were limited in high-quality RCTs, the long-term effects are not fully established.

Evidence in Special Populations

Research was studied for certain groups where symptoms may vary in intensity or where the response to medication can differ from the general adult population. Specifically, studies were evaluated in older adults (typically age 65 and over) and adults facing conditions involving periods of heightened symptoms, such as insomnia that occurs alongside advanced disease.

Findings indicate that measurements related to sleep latency and reported quality may follow patterns similar to the general population; however, the subgroup findings are uncertain due to smaller study sizes.

What Research Questions and Uncertainties Remain

The most significant gap is the lack of robust, long-term (over four weeks) RCTs, meaning the long-term effects are not fully established regarding sustained sleep metrics or patterns related to tolerance. Furthermore, comparative evidence is lacking for Zoperil against newer sleep agents, making it difficult to contextualize its place in the broader evidence landscape. The sample sizes were modest in many of the studies focusing on special populations, and thus subgroup findings are uncertain.

Frequently Asked Questions (FAQ)

Common questions about Zoperil (FAQ)


Q: How quickly should I feel a difference after starting Zoperil?

Zoperil is designed to work quickly to help with sleep initiation. Official regulatory information indicates the drug is rapidly absorbed and starts to work in approximately one hour. The recommended protocol is that it is taken immediately before retiring, and a full seven to eight hours of sleep time should be available after the dose.


Q: How long does Zoperil stay in your system after you stop taking it?

The drug's elimination half-life is typically reported to be about four to five hours in healthy adults. This means it takes this amount of time for the concentration of the medication in the bloodstream to reduce by half. The half-life may be longer for older adults or those with impaired liver or kidney function. Next-day impairment is a key safety consideration because residual effects can carry over.


Q: What happens if I miss a dose of Zoperil?

If a dose is missed after the usual bedtime or if a full seven to eight hours of dedicated sleep cannot be guaranteed, official guidance states that the dose should be skipped entirely. The medication should not be re-administered within the same night, nor should an extra dose be taken to make up for a forgotten one.


Q: Is it normal to feel a little dizzy when first taking Zoperil?

Dizziness is documented in regulatory documents as a common adverse reaction associated with Zoperil use. Common side effects, particularly those affecting the central nervous system, are frequently reported, especially when first starting treatment. Patients are generally advised to discuss any side effects with a healthcare provider.


Q: Is fatigue a common side effect of Zoperil?

Official regulatory safety information lists somnolence (drowsiness) among the common adverse reactions. The feeling of being physically or mentally tired (fatigue) is closely related and has also been reported in safety information. Due to the potential for next-day drowsiness, the drug is intended for use when a full night's sleep is possible.


Q: Does Zoperil affect my ability to drive or operate machinery?

Yes. Zoperil is a Central Nervous System (CNS) depressant and carries a significant risk of next-day impairment, including drowsiness and reduced motor coordination. Additionally, complex sleep behaviors, such as sleep-driving, have been documented, leading to strict warnings about activities that require full alertness the day after use.


Q: Can Zoperil affect fertility in men or women?

Official regulatory guidance states there is no evidence to suggest that taking Zoperil reduces fertility in either men or women. However, patients who are planning a pregnancy should review their current treatment with a healthcare provider.


Q: What are the risks of taking Zoperil during pregnancy?

Zoperil is generally not recommended during pregnancy due to limited data on its use. If it is taken toward the end of pregnancy, there is a possibility that it may cause withdrawal symptoms in the newborn baby, such as agitation or shaking. If this occurs, the newborn may require extra monitoring in the hospital.


Q: What should I do if I accidentally take two doses of Zoperil close together?

Taking more than the prescribed dose, or taking two doses close together, can be dangerous and is considered an overdose. Symptoms can range from deep sleep and confusion to more severe issues like shallow breathing or very low blood pressure. If an overdose is suspected, emergency medical attention should be sought immediately.


Q: Do you get withdrawal symptoms if you stop taking Zoperil suddenly?

Yes, there is a documented risk of experiencing withdrawal symptoms (e.g., anxiety, abnormal dreams, or nausea) if Zoperil is stopped abruptly. For this reason, a gradual cessation (tapering off) is officially recommended by regulatory bodies.


Q: Does Zoperil interact with birth control pills?

Zoperil is primarily broken down in the liver by the CYP3A4 enzyme. Any other medicine, supplement, or vitamin that significantly affects this enzyme could change the concentration of Zoperil in your system. Patients are generally advised to disclose all medications, supplements, and vitamins to their healthcare provider.


Q: Is Zoperil chemically similar to any older, discontinued drugs?

Zoperil (Zopiclone) is categorized as a Z-drug and belongs to the cyclopyrrolone chemical class. While it is structurally different from older benzodiazepine medications, it functions similarly in the brain by enhancing the effects of the calming neurotransmitter GABA.


Q: Does Zoperil work immediately or does it take a few weeks to build up?

Official regulatory information confirms that Zoperil works quickly, with an onset of action in about one hour. It is intended for the short-term management of temporary sleep difficulties and does not require a few weeks to accumulate or 'build up' in the body to become effective.


Q: Can I take Zoperil with my daily multivitamin?

Regulatory guidance advises patients to tell their doctor or pharmacist about any other medications they are taking, including all vitamins and supplements. This precaution helps minimize the risk of unintended interactions that could affect the medication's safety or effectiveness.


Q: Is Zoperil a drug that you have to take forever?

No. Official guidance strictly mandates that the overall course of treatment for Zoperil must be short-term. The total duration of use should not exceed a maximum of four continuous weeks, and this limit includes any time spent gradually reducing the dose before stopping.


Q: What is the typical duration of a Zoperil treatment course?

Treatment with Zoperil should be for the shortest time possible to manage acute sleep difficulties. Official guidelines mandate that the maximum duration of use must not exceed four continuous weeks, and this includes any necessary period of dose reduction.


Q: Do I need to take Zoperil with food or on an empty stomach?

Official regulatory information advises that administration of Zoperil should avoid taking it with or immediately after consuming a high-fat meal. This is because a high-fat meal may slow down the drug's absorption rate, which could potentially decrease its expected effect on sleep onset.


Q: Why do some people experience trouble sleeping after taking Zoperil?

Regulatory information notes that if insomnia persists or worsens after 7 to 10 days of taking the drug, this should be discussed with a professional. In this case, the underlying cause of the sleep issue may require further professional evaluation. Additionally, stopping the medication abruptly can sometimes cause the temporary worsening of sleep difficulties, known as rebound insomnia.


Q: Can Zoperil be cut in half or crushed for easier swallowing?

No. Zoperil is an oral formulation that is typically a film-coated tablet and must be swallowed whole with water. Official administration instructions state that the tablet should not be crushed or chewed.


Q: Is it okay to store Zoperil in the bathroom cabinet?

General regulatory storage guidelines require that Zoperil be kept in a cool, dry place, protected from excessive heat and moisture. Since bathroom cabinets often contain high levels of moisture, general best practices for prescription drugs emphasize storage in a location that is consistently dry, and always out of the sight and reach of children.


Q: What are the signs that Zoperil might not be working for me?

According to official product information, if your sleep difficulties persist or worsen after taking the medication for seven to ten days, this may be a sign the treatment is not effective. In this case, further evaluation of the underlying cause of the sleep issue by a healthcare provider may be necessary.


Q: How is Zoperil different from a placebo in clinical trials?

Research from clinical trials shows that participants receiving Zoperil reported measurable differences compared to those receiving an inactive placebo. Specifically, the findings indicated a difference in the time participants took to fall asleep (Sleep Onset Latency) and the total amount of time they spent sleeping.


Q: What is the best time of day to take Zoperil?

Zoperil must be taken only once daily, administered strictly immediately before retiring for the night. The dosing protocol requires that a full seven to eight hours of dedicated sleep time be possible after the dose is taken.


Q: Why do doctors recommend gradually stopping Zoperil instead of quitting all at once?

Gradual cessation, or tapering off, is officially recommended to minimize the risk of adverse effects. Stopping suddenly can lead to the temporary return of insomnia, known as rebound insomnia, and can also trigger withdrawal symptoms.


Q: Does Zoperil cause sensitivity to the sun?

Unusual skin reactions to sun exposure, known as photosensitivity, have been documented in the regulatory safety information for Zoperil, although this is reported as a rare adverse reaction.


Q: Is Zoperil used for pain management in some cases?

Official regulatory documents indicate that Zoperil is only indicated for the temporary management of sleep disorder difficulties (insomnia). It is not approved or indicated by regulatory authorities for the management of pain.


Q: Are there any specific dietary restrictions while taking Zoperil?

The primary dietary caution noted in the regulatory information is to avoid consuming Zoperil with a high-fat meal, as this may decrease its effectiveness. There are no broad, general dietary restrictions otherwise indicated.


Q: How often is Zoperil typically prescribed (once a day, twice a day, etc.)?

Zoperil is strictly used according to a single-dose protocol. It is administered only once daily, and this single dose must be taken immediately before going to bed.


Q: Can Zoperil affect your mood or mental state?

Yes, official safety information documents note that Zoperil carries a risk of effects on mental state. These have included reports of abnormal thinking, the potential worsening of depression, agitation, and, in rare cases, hallucinations.


Q: Does Zoperil change your blood pressure?

Low blood pressure (hypotension) has been reported in safety information, particularly in cases where the maximum recommended dose is exceeded. This can potentially lead to symptoms such as dizziness or feeling light-headed.


Q: What are the signs of angioedema (swelling of the face, tongue, or throat) from Zoperil?

Angioedema is listed as a severe hypersensitivity reaction. The signs are described as swelling of the face, tongue, or throat. Because this is considered a serious adverse event in regulatory documents, immediate emergency medical attention is necessary if these signs are observed.

How should Zoperil be stored and disposed of?

How to Store and Dispose of Zoperil?

Because specific, product-level regulatory information for Zoperil is not currently available in public government sources, storage and disposal must adhere to general best practices and federal guidelines for prescription medication.

Storage & Disposal Scope Requirement/Classification
Storage Temperature & Conditions The drug must be stored as directed on its label. Typically, this means in a cool, dry place, away from excessive heat, moisture, and direct light to maintain potency.
Child Protection Always store Zoperil and all medicines out of the sight and reach of children and pets, ideally in a locked cabinet or container.
Disposal Do not flush unused medication down a toilet or pour it down a sink unless the drug is specifically listed on the federal 'flush list.'
Preferred Disposal Method The safest way to dispose of expired or unused Zoperil is by using a community drug take-back program or a DEA-authorized disposal kiosk at a local pharmacy or police station.

If a take-back program is not readily available, remove the drug from its original container, mix it with an undesirable substance (such as coffee grounds or cat litter), place the mixture in a sealed bag or container, and then discard it in the household trash. Always scratch out personal information on the prescription label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zoperil found in:

A-Z Index: